1542 related articles for article (PubMed ID: 8623181)
21. Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection.
Palmer SM; Baz MA; Sanders L; Miralles AP; Lawrence CM; Rea JB; Zander DS; Edwards LJ; Staples ED; Tapson VF; Davis RD
Transplantation; 2001 Jun; 71(12):1772-6. PubMed ID: 11455257
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
Miller J; Mendez R; Pirsch JD; Jensik SC
Transplantation; 2000 Mar; 69(5):875-80. PubMed ID: 10755543
[TBL] [Abstract][Full Text] [Related]
23. Mycophenolate versus azathioprine for kidney transplantation: a 15-year follow-up of a randomized trial.
Clayton PA; McDonald SP; Chapman JR; Chadban SJ
Transplantation; 2012 Jul; 94(2):152-8. PubMed ID: 22728292
[TBL] [Abstract][Full Text] [Related]
24. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.
Ahsan N; Johnson C; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
Transplantation; 2001 Jul; 72(2):245-50. PubMed ID: 11477347
[TBL] [Abstract][Full Text] [Related]
25. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.
Sterneck M; Fischer L; Gahlemann C; Gundlach M; Rogiers X; Broelsch C
Ann Transplant; 2000; 5(1):43-6. PubMed ID: 10850611
[TBL] [Abstract][Full Text] [Related]
26. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
[TBL] [Abstract][Full Text] [Related]
27. Comparison of azathioprine and mycophenolate mofetil for the prevention of acute rejection in recipients of pancreas transplantation.
Oh JM; Wiland AM; Klassen DK; Weidle PJ; Bartlett ST
J Clin Pharmacol; 2001 Aug; 41(8):861-9. PubMed ID: 11504274
[TBL] [Abstract][Full Text] [Related]
28. The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation.
Satoh S; Tada H; Murakami M; Tsuchiya N; Inoue T; Togashi H; Matsuura S; Hayase Y; Suzuki T; Habuchi T
Transplant Proc; 2005 May; 37(4):1751-3. PubMed ID: 15919454
[TBL] [Abstract][Full Text] [Related]
29. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses.
Moreso F; Serón D; Morales JM; Cruzado JM; Gil-Vernet S; Pérez JL; Fulladosa X; Andrés A; Grinyó JM
Clin Transplant; 1998 Jun; 12(3):198-205. PubMed ID: 9642510
[TBL] [Abstract][Full Text] [Related]
30. [Use of mycophenolate mofetil (MMF) in kidney transplantation: results of a single center trial].
Pastural M; Barrou B; Golmard JL; Gorichon-Radideau E; Manighetti J; Ourahma S; Benalia H; Mouquet C; Chatelain C; Bitker MO
Prog Urol; 1999 Feb; 9(1):19-25. PubMed ID: 10212949
[TBL] [Abstract][Full Text] [Related]
31. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft.
Grinyó JM; Gil-Vernet S; Seron D; Hueso M; Fulladosa X; Cruzado JM; Moreso F; Fernandez A; Torras J; Riera L; Castelao AM; Alsina J
Nephrol Dial Transplant; 1998 Oct; 13(10):2601-4. PubMed ID: 9794567
[TBL] [Abstract][Full Text] [Related]
32. Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation.
Zhu B; Liu Z; Wu C; Wang P; Wang X; Xu H
Transplant Proc; 2008 Sep; 40(7):2258-61. PubMed ID: 18790207
[TBL] [Abstract][Full Text] [Related]
33. Mycophenolate mofetil (MMF) versus azathioprine (AZA) in pancreas transplantation: a single-center experience.
Rigotti P; Cadrobbi R; Baldan N; Sarzo G; Parise P; Furian L; Marchini F; Ancona E
Clin Nephrol; 2000 Apr; 53(4):suppl 52-4. PubMed ID: 10809437
[TBL] [Abstract][Full Text] [Related]
34. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
Pham PT; Pham PC
Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
[TBL] [Abstract][Full Text] [Related]
35. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience.
Ross DJ; Waters PF; Levine M; Kramer M; Ruzevich S; Kass RM
J Heart Lung Transplant; 1998 Aug; 17(8):768-74. PubMed ID: 9730425
[TBL] [Abstract][Full Text] [Related]
36. [Mycophenolate mofetil (MMF) for prevention of kidney transplant rejection. A new immunosuppressive agent. International Mycophenolate Mofetil Study Group].
Carl S; Wiesel M; Staehler G
Urologe A; 1998 May; 37(3):282-6. PubMed ID: 9646426
[TBL] [Abstract][Full Text] [Related]
37. Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?
Basic-Jukic N; Kes P; Bubic-Filipi LJ; Puretic Z; Brunetta B; Pasini J
Transplant Proc; 2005 Mar; 37(2):850-1. PubMed ID: 15848553
[TBL] [Abstract][Full Text] [Related]
38. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
Włodarczyk Z; Wałaszewski J; Perner F; Vitko S; Ostrowski M; Bachleda P; Kokot F; Klinger M; Szenohradsky P; Studenik P; Navratil P; Asztalos L; Rutkowski B; Nagy KK; Hickey D
Ann Transplant; 2002; 7(3):28-31. PubMed ID: 12465429
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of mycophenolate mofetil versus azathioprine after renal transplantation: a systematic review.
Wang K; Zhang H; Li Y; Wei Q; Li H; Yang Y; Lu Y
Transplant Proc; 2004 Sep; 36(7):2071-2. PubMed ID: 15518749
[TBL] [Abstract][Full Text] [Related]
40. Randomized trial of conversion from mycophenolate mofetil to azathioprine 6 months after renal allograft transplantation.
Wüthrich RP; Cicvara S; Ambühl PM; Binswanger U
Nephrol Dial Transplant; 2000 Aug; 15(8):1228-31. PubMed ID: 10910450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]